Understanding Opioid Diversion in Safer Supply Programs
Author Information
Author(s): Olding Michelle, Rudzinski Katherine, Schmidt Rose, Kolla Gillian, German Danielle, Sereda Andrea, Strike Carol, Guta Adrian
Primary Institution: University of Toronto
Hypothesis
How and why is opioid diversion occurring in safer supply programs, and how may it be best managed?
Conclusion
Diversion in safer supply programs may be best addressed by expanding medication options to better match patients’ substance use needs, alongside wraparound social supports.
Supporting Evidence
- Diversion reportedly occurred through compassionate sharing to manage withdrawal and overdose risk.
- Patients reported they consumed all or most of their prescribed medications and rarely shared or sold their doses.
- Providers described using nonjudgmental conversations to understand patients’ needs and develop mitigation strategies.
Takeaway
Some people share or sell their prescribed medications to help friends or because they need more drugs than they get. It's important to find better ways to help them without punishing them.
Methodology
Qualitative interviews and sociodemographic questionnaires were conducted with patients and providers across 4 safer supply programs in Ontario, Canada.
Potential Biases
Participants may emphasize socially acceptable forms of diversion, such as compassionate sharing.
Limitations
Patients may be uncomfortable disclosing their experiences with diversion, leading to potential social desirability bias.
Participant Demographics
{"patients":{"total":52,"gender":{"men":29,"women":23},"race":{"Black":1,"Indigenous":9,"Latino":1,"White":41},"mean_age":46.5},"providers":{"total":21,"gender":{"men":6,"women":13,"nonbinary":2},"mean_age":37.6}}
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website